The Ability of CMV-Specific Elispot Assay to Predict Outcome of Low-Level CMV Reactivation in Hematopoietic Cell Transplant Recipients

被引：0
|
作者：
Ariza-Heredia, Ella J. [1 ]
Shah, Dimpy P. [1 ]
El Chaer, Firas [1 ]
El Haddad, Lynn [1 ]
El-Haddad, Danielle [1 ]
Prayag, Amrita [1 ]
Nesher, Lior [1 ]
Rezvani, Katy [2 ]
Shpall, Elizabeth J. [2 ]
Chemaly, Roy F. [1 ]
机构：
[1] Univ Texas MD Anderson Canc Ctr, Infect Dis Infect Control & Employee Hlth, Houston, TX 77030 USA
[2] Univ Texas MD Anderson Canc Ctr, Dept Stem Cell Transplantat & Cellular Therapy, Houston, TX 77030 USA
来源：
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION | 2017年 / 23卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
219
引用
收藏
页码：S175 / S175
页数：1
相关论文
共 50 条
  • [41] The Degree of CMV-Specific T Cell Response Is Related with Infection Complications in Heart Transplant Recipients
    Youn, J.
    Lee, J.
    Han, S.
    Kang, S.
    Shin, E.
    JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2017, 36 (04): : S47 - S48
  • [42] CMV Viremia and Development of CMV-Specific Cytotoxic T-Cells (CMV-Tc) in Pediatric Renal Transplant Recipients.
    Pizzo, H.
    Shin, B.
    Toyoda, M.
    Jordan, S.
    Puliyanda, D.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2018, 18 : 946 - 946
  • [43] Kinetics of CMV-specific t-cells from pre-to-posttransplantation predict outcomes in CMV-seronegative kidney transplant recipients
    Schachtner, Thomas
    Stein, Maik
    Reinke, Pera
    TRANSPLANTATION, 2016, 100 (07) : S196 - S196
  • [44] CMV seropositive donor selection for CMV seropositive stem cell transplant recipients reduces CMV reactivation frequency and duration
    Cekauskiene, R.
    Maciutaite, E.
    Lizaitis, M.
    Simutiene, L.
    Trociukas, I.
    Griskevicius, L.
    BONE MARROW TRANSPLANTATION, 2017, 52 : S178 - S178
  • [45] Functional Signatures Revealed By Deep Phenotyping of CMV-Specific CD8+T Cells Predict Risk of Early CMV Reactivation after Allogeneic Hematopoietic Cell Transplantation
    Camargo, Jose F.
    Wieder, Eric
    Kimble, Erik
    Benjamin, Cara
    Kolonias, Despina
    Bravo, Gabriela
    Komanduri, Krishna
    BLOOD, 2017, 130
  • [46] Functional Signatures Revealed by Deep Phenotyping of CMV-Specific CD8+ T Cells Predict Risk of Early CMV Reactivation After Allogeneic Hematopoietic Cell Transplantation
    不详
    CLINICAL ADVANCES IN HEMATOLOGY & ONCOLOGY, 2018, 16 (04) : 15 - 16
  • [47] RELIABLE ASSAY FOR MONITORING CMV-SPECIFIC T CELL IMMUNITY FOLLOWING ALLOGENEIC HEMATOPOIETIC CELL TRANSPLANTATION
    Brix, L.
    Pan, D.
    Halgreen, C.
    Hahn, T.
    Pedersen, H.
    Wallace, P.
    Mcarthy, Philip
    Pan, Dalin
    Jacobsen, Kivin
    Zhang, Yali
    Tario, Joseph
    BONE MARROW TRANSPLANTATION, 2014, 49 : S345 - S345
  • [48] Functional Signatures Revealed by Deep Phenotyping of CMV-Specific CD8+T Cells Predict Risk of Early CMV Reactivation after Allogeneic Hematopoietic Cell Transplantation
    Camargo, Jose F.
    Wieder, Eric
    Kimble, Erik
    Benjamin, Cara L.
    Kolonias, Despina
    Bravo, Gabriela
    Komanduri, Krishna V.
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2018, 24 (03) : S88 - S88
  • [49] The Presence of CMV-Specific T-Cells in CMV-Seronegative Kidney Transplant Recipients Predicts Outcome After Kidney Transplantation.
    Schachtner, T.
    Stein, M.
    Reinke, P.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2016, 16 : 310 - 311
  • [50] Third Party CMV-Specific Cytotoxic T Cells for Treatment of Antiviral Resistant CMV Infection after Hematopoietic Stem Cell Transplant
    Prockop, Susan
    Doubrovina, Ekaterina
    Hasan, Aisha N.
    Dahi, Parastoo B.
    Giralt, Sergio
    Koehne, Guenther
    Kernan, Nancy A.
    Papadopoulos, Esperanza B.
    Lehrman, Rachel
    Rodriguez-Sanchez, Irene
    O'Reilly, Richard J.
    BLOOD, 2016, 128 (22)
12345